Cited 8 times in
Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 권오찬 | - |
dc.contributor.author | 박민찬 | - |
dc.contributor.author | 박용범 | - |
dc.contributor.author | 박정환 | - |
dc.contributor.author | 송정식 | - |
dc.contributor.author | 이상원 | - |
dc.date.accessioned | 2020-12-01T17:51:14Z | - |
dc.date.available | 2020-12-01T17:51:14Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/180483 | - |
dc.description.abstract | Purpose: To compare the clinical characteristics and renal outcomes between patients who initially had lupus nephritis (LN) at the onset of systemic lupus erythematosus (SLE) (initial-onset LN) and those who developed LN within 5 years after SLE onset (early-onset LN). Materials and methods: SLE patients with biopsy-proven LN were retrospectively reviewed. The clinical parameters and renal outcomes were compared between initial-onset and early-onset LN groups. We used Cox regression analysis to estimate risk of worse renal outcomes according to the onset time of LN. Results: Of all 136 LN patients, 92 (67.6%) and 44 (32.4%) patients were classified into the initial-onset and early-onset LN groups, respectively. The initial-onset LN group had higher prevalences of class IV LN (54.3% vs. 34.1%, p=0.027), impaired renal function (34.8% vs. 11.4%, p=0.004), microscopic hematuria (73.9% vs. 54.5%, p=0.024), and higher urine protein/creatinine ratio [4626.1 (2180.0-6788.3) mg/g vs. 2410.0 (1265.0-5168.5) mg/g, p=0.006] at LN diagnosis. Renal relapse (46.3% vs. 25.7%, p=0.039) and progression to chronic kidney disease (CKD) or end-stage renal disease (ESRD) were more common (24.4% vs. 8.3%, p=0.042) in the initial-onset LN group. In Cox regression analysis, the initial-onset LN group had higher risks of renal relapse [adjusted hazard ratio (HR) 3.56, 95% confidence interval (CI) 1.51-8.35, p=0.004] and progression to CKD or ESRD (adjusted HR 4.57, 95% CI 1.03-20.17, p=0.045), compared with the early-onset LN group. Conclusion: Patients with LN at SLE onset may have more severe renal presentations and experience worse renal outcomes than those who develop LN within 5 years. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Yonsei University | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Biopsy | - |
dc.subject.MESH | Disease Progression | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kidney / physiopathology* | - |
dc.subject.MESH | Kidney Failure, Chronic / etiology* | - |
dc.subject.MESH | Lupus Erythematosus, Systemic / pathology* | - |
dc.subject.MESH | Lupus Erythematosus, Systemic / therapy | - |
dc.subject.MESH | Lupus Nephritis / complications | - |
dc.subject.MESH | Lupus Nephritis / pathology* | - |
dc.subject.MESH | Lupus Nephritis / therapy | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Young Adult | - |
dc.title | Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Oh Chan Kwon | - |
dc.contributor.googleauthor | Jung Hwan Park | - |
dc.contributor.googleauthor | Sang Won Lee | - |
dc.contributor.googleauthor | Jason Jungsik Song | - |
dc.contributor.googleauthor | Yong Beom Park | - |
dc.contributor.googleauthor | Min Chan Park | - |
dc.identifier.doi | 10.3349/ymj.2020.61.11.951 | - |
dc.contributor.localId | A05818 | - |
dc.contributor.localId | A01470 | - |
dc.contributor.localId | A01579 | - |
dc.contributor.localId | A05920 | - |
dc.contributor.localId | A02057 | - |
dc.contributor.localId | A02824 | - |
dc.relation.journalcode | J02813 | - |
dc.identifier.eissn | 1976-2437 | - |
dc.identifier.pmid | 33107238 | - |
dc.subject.keyword | Systemic lupus erythematosus | - |
dc.subject.keyword | lupus nephritis | - |
dc.subject.keyword | prognosis | - |
dc.contributor.alternativeName | Kwon, Oh Chan | - |
dc.contributor.affiliatedAuthor | 권오찬 | - |
dc.contributor.affiliatedAuthor | 박민찬 | - |
dc.contributor.affiliatedAuthor | 박용범 | - |
dc.contributor.affiliatedAuthor | 박정환 | - |
dc.contributor.affiliatedAuthor | 송정식 | - |
dc.contributor.affiliatedAuthor | 이상원 | - |
dc.citation.volume | 61 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 951 | - |
dc.citation.endPage | 957 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.61(11) : 951-957, 2020-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.